Novel findings indicate that Retatru tide , a dual agonist targeting gut hormone and gastric inhibitory peptide receptors , appears to be a turning point in body control . Early human trials have https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026